SynthesisFrontiers in oncology2019

Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia With Losing Major Molecular Response as a Definition for Molecular Relapse: A Systematic Review and Meta-Analysis.

Kang-Kang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.